Delivery Order SPE2DB24D1205-SPE2DB25FCZEE
- Not listed
- The Defense Logistics Agency awarded a $4,156.56 delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Orgovyx 120 mg tablets in quantities of 30 units. This is a firm fixed price delivery order with an ultimate completion date of August 11, 2025, and represents a non-set-aside, competitively awarded contract. The pharmaceutical product will be delivered to the Conshohocken, Pennsylvania location, which serves as AmerisourceBergen's corporate headquarters and...
- The Defense Logistics Agency awarded a delivery order valued at $24,939.36 to AmerisourceBergen Drug Corp for 30-unit supplies of Orgovyx 120 mg tablets, with an ultimate completion date of August 26, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which carries a potential value of $999,999,999.00 through December 2026. The place of performance is located...
- The Defense Logistics Agency awarded a delivery order valued at $2,771.04 to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Orgovyx 120 mg tablets (30-unit packages). This is a firm fixed-price, non-set-aside contract with a completion date of August 14, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. Orgovyx is a prescription medication used in the treatment of prostate cancer, representing the type of specialized pharmaceutical...
- The Defense Logistics Agency awarded a $1,385.52 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 30 units of Orgovyx 120 mg tablets, with an ultimate completion date of August 25, 2025. This non-set-aside contract was competitively awarded on August 4, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a delivery order valued at $4,156.56 to AmerisourceBergen Drug Corp for the supply of Orgovyx 120 mg tablets (30-count units) on August 5, 2025, with an ultimate completion date of August 26, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,771.04 for 30 tablets of Orgovyx 120 mg on July 30, 2025, with an ultimate completion date of August 20, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and is funded through the Medical Supply Chain, a defense-oriented federal agency supporting military and veteran healthcare systems. The place of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 30 tablets of Orgovyx 120 mg with a firm fixed price ceiling value of $1,385.52. This non-set-aside delivery order was awarded on July 31, 2025, and carries an ultimate completion date of August 21, 2025. The contract specifies performance at AmerisourceBergen's Conshohocken, Pennsylvania location, where the company maintains its corporate office and serves as a major pharmaceutical distributor for federal...
- The Defense Logistics Agency awarded a delivery order valued at $16,626.24 to AmerisourceBergen Drug Corp for the supply of Orgovyx 120 mg tablets (30-count units) on July 21, 2025, with an ultimate completion date of August 11, 2025. This is a firm fixed price delivery order with no set-aside designation, indicating competitive award. The product will be delivered to AmerisourceBergen's location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $5,542.08 to AmerisourceBergen Drug Corp for the supply of Orgovyx 120 mg tablets (30-count unit of use packaging) on July 21, 2025, with an ultimate completion date of August 11, 2025. This competitively awarded, firm fixed-price contract with no set-aside designation represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and...
- The Defense Logistics Agency awarded a $1,385.52 firm fixed price delivery order to AmerisourceBergen Drug Corp for 30 tablets of Orgovyx 120 mg, with an ultimate completion date of August 11, 2025. This non-set-aside contract represents a single delivery order under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support Medical. The work will be performed at the contractor's corporate office in Conshohocken, Pennsylvania, supporting federal pharmaceutical...
- SPE2DB24D1205Indefinite Delivery Contract
- SPE2DB24D1205-SPE2DB25FCZEEDelivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $1,385.52 firm fixed price delivery order for 30 tablets of Orgovyx 120 mg on August 4, 2025, with an ultimate completion date of August 25, 2025. This non-set-aside competitive award is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The pharmaceutical product will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. Orgovyx is a prescription medication used in prostate cancer treatment, reflecting the company's role as a critical supplier of specialized medical commodities to support military healthcare systems. As a major pharmaceutical distributor headquartered in Pennsylvania, AmerisourceBergen Drug Corp serves as a prime vendor for federal medical procurement, supplying an extensive portfolio of brand-name and generic medications, vaccines, medical devices, and specialized healthcare products across multiple therapeutic domains. The company's substantial IDC with DLA demonstrates its capability to meet federal procurement requirements through open competition and provides a flexible vehicle for delivering critical pharmaceutical support to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems globally. This delivery order represents a routine transactional fulfillment under that comprehensive contract vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 8/4/25 |